Employees
Göran Nordström
Founding Partner / Chief Executive Officer
Over 30 years of experience in leading financial positions.
Education: LL.B., Master of Laws, University of Stockholm, Financial Analyst, IFL.
Henrik Rhenman
Founding Partner / Chief Investment Officer
Over 25 years of experience in portfolio management.
Education: Biochemist, Royal Institute of Technology, B.Sc., Stockholm School of Economics.
Susanna Urdmark
Co-Head/Senior Portfolio Manager (RHE L/S)
Employed at Rhenman & Partners since: 2017. 25 years of experience from investing in the healthcare sector.
Education: M.Sc., Stockholm School of Economics. M.A. in Medical Sciences, Boston University School of Medicine.
Kaspar Hållsten
Portfolio Manager (RHE L/S)
Employed at Rhenman & Partners since: 2017.
Education: Business Administration, Finance, B.Sc., Stockholm Business School.
Staffan Knafve
Senior Advisor
Affiliated to Rhenman & Partners since: 2012.
Over 25 years of experience in the stock market.
Education: LL.B., Master of Laws, University of Stockholm.
Hugo Schmidt
Analyst (RHE L/S)
Employed at Rhenman & Partners since: 2019.
Education: B.Sc. Business & Economics, Stockholm School of Economics.
Carl Grevelius
Founding Partner / Head of Investor Relations
Over 20 years of international fund and equity experience.
Education: B.Sc., Uppsala University.
Anders Grelsson
Investor Relations Sweden
Employed at Rhenman & Partners since: 2011.
Over 25 years of experience in financial management.
Camilla Hermansson
Assistant, Client Relations Sweden
Employed at Rhenman & Partners since: 2011.
Board of Directors
Professor Hans Wigzell
Chairman of the Board
Professor of Immunology, Karolinska Institutet. Former president of Karolinska Institutet, head of the Infectious Disease Institute, the State Bacteriological Laboratory and chair of Karolinska Institutet’s Nobel Committee. Member of the Royal Academy of Sciences and the Royal Swedish Academy of Sciences IVA. Total number of active board assignments: 4.
Birgitta Stymne Göransson
Director
M.Sc. in Chemistry/Biotechnology, Royal Institute of Technology (KTH), and MBA Harvard Business School. Board member Elekta AB, LEO Pharma A/S, Pandora A/S and Enea AB. Chairman of the Boards of BCB Medical Oy and MAG Interactive. Previously CEO of Memira Group, COO at Telefos, McKinsey Associate and Product manager at Gambro. Total number of active board assignments: 7
Håkan Åström
Director
Honorary Doctorate in Medicine and Bachelor of Science in Economics. Chair of Affibody Medical AB, PledPharma and 20 North Street (RP) AB. Former Chair of Swedish Orphan Biovitrum AB (SOBI), Orexo AB and Ferrosan AS. CEO of Pharmacia Kabi and Astra Pharmaceutical Ltd. Several other leading positions in the pharmaceutical industry Total number of board appointments: 6
Göran Nordström
Director
Law degree, Stockholm University, and Financial Analyst, IFL Founders and CEO, Rhenman & Partners. Former head of Private Banking, Kaupthing Bank Sweden. CEO, Carnegie Asset Management AB. CEO, Carnegie Pension Consulting. Vice President, Midland Montague Bank/HSBC. Portfolio manager, Handelsbanken Asset Management. Tax expert, County Administrative Board in Stockholm County. Total number of active board assignments: 3.
Henrik Rhenman
Director
Biochemist, Royal Institute of Technology and M.Sc., School of Business. Founder and Managing Director, Rhenman & Partners. Former Founder & CIO, Carnegie Healthcare Funds, Carnegie Investment Bank. CEO, Portfolio Manager, SG Cowen, Boston. Portfolio manager, SEB Pharmaceutical Fund. Head of Analysis, Hagströmer & Qviberg. Total number of active board assignments: 2.
Carl Grevelius
Secretary
Bsc, Uppsala University. Founder and Head of Investor Relations, Rhenman & Partners. Former portfolio manager, Carnegie Investment Bank, Stockholm. Founder and portfolio manager, Absolute Plus, Zurich. Equity analyst, ABG Sundal Collier, London and Zurich. Portfolio Strategist, Fidelity Investments, Luxembourg and London.